Hyderabad Mobilises for Pulse Polio Drive Targeting 5.22 Lakh Children
Health officials in Hyderabad have launched an intensive pulse polio campaign aimed at immunising over half a million children before the year’s end. The effort arrives amid concerns of waning vaccine coverage in urban pockets of the state.

The municipal health department has deployed a network of mobile vaccination units, community volunteers, and school partnerships to reach the targeted cohort of 5.22 lakh children across Hyderabad’s densely populated neighbourhoods. Campaign coordinators have emphasized the importance of completing the three‑dose schedule within a narrow window to sustain herd immunity and prevent resurgence of poliovirus transmission. The drive is supported by central government funding and aligns with the national eradication timeline that seeks to certify India as polio‑free.
Underlying the initiative is a persistent challenge of vaccine hesitancy and logistical bottlenecks in slum areas where health infrastructure is limited. Recent surveys have indicated pockets of low immunisation rates, driven by misinformation and limited access to healthcare facilities. The city’s health authorities have responded by intensifying community outreach, leveraging local religious leaders and media to dispel myths, and ensuring cold‑chain integrity for vaccine potency. This coordinated approach reflects a broader public‑health strategy to address gaps that could undermine national disease‑elimination goals.
The immediate impact of the campaign includes a surge in vaccination registrations and a measurable uptick in community participation, as reported by field officers. Early data suggest that the drive has already inoculated a significant proportion of the target group, reducing the risk of poliovirus circulation in the region. In the coming months, sustained surveillance and follow‑up doses will be critical to consolidating gains, while the success of Hyderabad’s effort may serve as a template for other Indian cities confronting similar public‑health hurdles.
Comments 0